kPNI und Forschung

Liebe PatientInnen, liebe KlientInnen,

auf dieser Seite gebe ich Ihnen einen kleinen Einblick in wissenschaftliche Paper zu kPNI- relevanten Themen.

  1. „The opioid effects of gluten exorphins: asymptomatic celiac disease.“
    Leo Pruimboom and Karin de Punder
    Journal of Health, Population and Nutrition 2015 33:24
    Veröffentlicht am 24.11.2015
  2. „Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer.“
    Fasano A
    Physiol Rev. 2011 Jan;91(1):151-75. doi: 10.1152/physrev.00003.2008.
  3. „Stress Induces Endotoxemia and Low-Grade Inflammation by Increasing Barrier Permeability.“
    Karin de Punder and Leo Pruimboom
  4. „Prevalence of Anti-Neu5Gc Antibodies in Patients with Hypothyroidism.“
    Phaedra Eleftheriou, Stavros Kynigopoulos, Alexandra Giovou, Alexandra Mazmanidi, John Yovos, Petros Skepastianos, Eleni Vagdatli, Christos Petrou, Dafni Papara, and Maria Efterpiou1
  5. „Chronic pain: a non-use diseas“
    Pruimboom L, van Dam AC
    Medical hypotheses 2007;68(3):506-11Epub 2006 Oct 30.
  6. „The role of the gut microbiota in energy metabolism and metabolic disease“
    Cani PD, Delzenne NM
    Curr Pharm Des. 2009;15(13):1546-58
  7. „Fructose, insulin resistance, and metabolic dyslipidemia.“
    Basciano H, Federico L, Adeli K
    Nutr Metab (Lond). Feb 21;2(1):5.
  8. „Fructose: a key factor in the development of metabolic syndrome and hypertension.“
    Khitan Z, Kim DH
    J Nutr Metab. 2013;2013:682673. doi: 10.1155/2013/682673. Epub 2013 May 25
  9. „Insulin resistance and skin diseases.“ M Napolitano, M Megna, G Monfrecola – The Scientific World Journal, 2015
  10.  „Use of bovine lactoferrin for Helicobacter pylori eradication“ Di Mario, Dig Liver Dis. 2003 Oct;35(10):706-10.